Skip to main content
. 2011 Sep 30;2:62. doi: 10.3389/fneur.2011.00062

Table 1.

Background data at presentation of 10 patients with visual loss due to tumor-related optic neuropathy.

Pt. No. Gender/age (year)* Follow-up (months) Laterality* Tumor type Symptoms (duration/months) Signs
1 F/9.1 4+ B Post. fossa astrocytoma Headache, diplopia (2 months) Esotropia, papilledema
2 M/6.2 8 B Post. fossa meduloblastoma Reduced vision, ataxia (2 months) Reduced vision, papilledema
3 M/8 79 B Pineal germinoma Headache, reduced vision, hearing loss (2 months) Reduced vision, Abnl. EOM (Parinaud), papilledema
4 M/7.1 12 B Craniopharyngioma Diplopia, falls (0.5 months) Reduced vision, papilledema
5 M/5 75 B Craniopharyngioma Headache Reduced vision, papilledema
6 F/5 48 B Craniopharyngioma Reduced vision, headache (3 months) Reduced vision, exotropia, optic atrophy
7 F/2.5 45 M Craniopharyngioma None Reduced vision, esotropia, mono-nystagmus, papilledema
8 M/6 192 M Optic nerve glioma None (Strabismus since birth) Reduced vision, VF hemianopia, optic atrophy
9 F/9 113 M Optic nerve glioma Headache, proptosis, reduced vision (8 months) Reduced vision, VF hemianopia, optic atrophy
10 F/12 26 M Optic nerve glioma Proptosis (1 months) Proptosis, reduced vision, swollen disk, CVO

Two children were totally asymptomatic at diagnosis. Seven of the eight symptomatic children had ocular symptoms already at presentation for the underlying disease. These included blurred vision (n = 4) with “bumping into objects” (in patient 3), diplopia (n = 2), and proptosis (n = 2). The diagnosis of the tumor was made on routine examination in two patients, during neuroimaging for neurofibromatosis type 1 in one patient, and during evaluation for new-onset strabismus, noted by the parents, in one patient. CVO, central vein occlusion; EOM, extraocular movement; M, monocular; B, bilateral; VF, visual field. *At presentation; +Parents refused follow-up; Neurofibromatosis.